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Abstract
Objective: To evaluate the in situ antibacterial activity of a mouthrinse with 0.2% Chlorhexidine (M-0.2% CHX) on
undisturbed de novo plaque-like biofilm (PL-biofilm) and on salivary flora up to 7 hours after its application.
Methods: A special acrylic appliance was designed, with 3 inserted glass disks on each buccal side, allowing for PL-biofilm
growth. Fifteen healthy volunteers wore the appliance for 48 hours and then performed an M-0.2% CHX; disks were
removed at 30 seconds and 1, 3, 5 and 7 hours after the mouth-rinsing. Applying a washout period, saliva samples were
collected from each volunteer at 30 seconds and 1, 3, 5 and 7 hours after performing an M-0.2% CHX. The PL-biofilm and
saliva samples were analysed by confocal laser scanning and epifluorescence microscopes, respectively.
Results: At 30 seconds after M-0.2% CHX, the levels of viable bacteria detected in saliva were significantly lower than those
observed in PL-biofilm. The difference in the percentage of live bacteria detected in saliva was significantly higher than that
observed in PL-biofilm at 5 and 7 hours after M-0.2% CHX.
Conclusion: After a single mouthrinse of the 0.2% CHX formulation tested in the present study, the 2-day PL-biofilm
presented a significantly higher resistance to this antiseptic in situ than that observed in salivary flora. However, this 0.2%
CHX formulation showed a higher substantivity on PL-biofilm than on salivary flora at 5 and 7 hours after mouth-rinsing,
which could be related to the slower growth rate of PL-biofilm and the possible reservoir function for antimicrobial agents
associated with the undisturbed de novo PL-biofilm.
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Introduction
The in vitro development of biofilm models have led to
significant advances in the study of oral biofilms [1]. However,
in vitro oral biofilm models tend to involve limited numbers of
species and, in addition, they are created under conditions that still
cannot adequately reflect the physiological situation in the oral
cavity [2–4]. Factors related to the oral cavity, such as the turnover
rate of saliva, the ability of antibacterial substances to adhere to
the pellicle of the tooth or the surface of soft tissues in order to
achieve their effects, and the interaction with unculturable
bacteria, cannot be modelled in in vitro experiments [5].
Consequently, at the present time, the scientific community
recognizes that in vitro models cannot guarantee the creation of
oral biofilms whose composition and structure is comparable with
those that form in situ [2–4,6]. For this reason, there is a need to
develop in situ biofilm models that can subsequently be analysed
intact ex vivo [2,7,8].
Studies have been published in the literature in which the in situ
antimicrobial activity of CHX on the plaque-like biofilm (PL-
biofilm) has been evaluated using microbiological plate culture
techniques [9,10]. However, numerous disadvantages associated
with the use of culture-dependent methods are well known [5,11].
Since Netuschil first used fluorescence techniques to investigate
dental plaque in 1983 [12], numerous authors have used
fluorescence methods to study the in situ antibacterial effect of
CHX on PL-biofilm. A common methodological characteristic of
all of these studies is that evaluation of the supragingival bacterial
plaque was performed on material previously removed from the
surface of the tooth [13–15], whereas the subgingival bacterial
plaque was obtained by paper point sampling or by mechanical
debridement [9,16]; this is likely to disturb the delicate three-
dimensional relationship of the cells, matrix, space, and substrate
[17–19]. Another disadvantage of this method, in which the dental
plaque is disturbed, is that the level of penetration of an
antimicrobial agent into the PL-biofilm cannot be evaluated as
the samples are dispersed for analysis [14]. This methodology
therefore provides an inadequate study of the architecture and
organization of in vivo PL-biofilm, as well as of the action of
antimicrobial agents on its structure [4,20].
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As a result, and in order to improve the methodology of such
studies, special removable appliances that include a number of
disks on which growth of the PL-biofilm can take place have
been designed [3,20–22]. Subsequently, this undisturbed PL-
biofilm is analysed using confocal laser scanning microscopy
(CLSM) and fluorescence solutions that permit the simultaneous
study of the three-dimensional structure of the biofilm and the
evaluation of bacterial viability [3,20–22]. Other techniques such
as fluorescence-labelled antibodies and fluorescence hybridisation
(FISH) have been frequently used in combination with CLSM to
analyse bacterial topography of in situ undisturbed PL-biofilm
[18,19,23,24]. With CLSM, biofilms can be studied in their
natural hydrated state, with no requirement for dehydration,
fixation, or staining [2,20,25]. In addition, the optical sectioning
properties of CLSM mean that very thin optical sections in the
horizontal plane (X–Y axes) can be taken at 0.5 to 2 mm
intervals, at increasing depths through the biofilm (from the
surface of the biofilm to its base), that are free from out-of-focus
blurring [5,18,25,26].
Consequently, at present, the scientific community considers
that the methodological design based on using of special
removable appliances (including disks) to obtain biofilm samples
and its analysis by CLSM (in combination with other microscopic
and microbiological techniques) is the most suitable approach for
studying the in situ architecture and physiology of undisturbed PL-
biofilm formed on surfaces, as well as the antibacterial effect of
antimicrobials on this microbial structure [8,17,20]. However,
there are few studies in the literature in which the effects of CHX
on in situ undisturbed PL-biofilm have been investigated applying
CLSM together with bacterial viability techniques [3,25,27,28].
The aim of the present study was to evaluate the in situ
antibacterial activity of a 0.2% CHX mouthrinse on undisturbed
de novo PL-biofilm up to 7 hours after its application, comparing
the results with those obtained on salivary flora.
Materials and Methods
This was a randomised, double-blind, crossover study of the
antibacterial efficacy of CHX on an in situ model of PL-biofilm
growth.
Selection of the study group
The study group was formed of 15 systemically healthy adult
volunteers between 20 and 45 years of age and who presented a
good oral health status: a minimum of 24 permanent teeth with no
evidence of gingivitis or periodontitis (Community Periodontal
Index score = 0) [29], and an absence of untreated caries. The
following exclusion criteria were applied: smoker, presence of
dental prostheses or orthodontic devices, antibiotic treatment or
routine use of oral antiseptics during the previous 3 months, and
presence of any systemic disease that could alter the production or
composition of the saliva. A professional tooth cleaning was
performed on all volunteers before starting the study.
This project was approved (number 2012/394) by the Clinical
Research Ethics Committee of Galicia. Written informed consent
was obtained from all participants in the study.
Production of the disk-holding splint
After considering a number of previously described in situ
models [3,20–22], an individualised splint of the lower arch was
created for each volunteer, which was able to hold 6 glass disks
(6 mm diameter, 1 mm thickness) polished at 800 grit. The
characteristics of this splint have been previously described by
authors [30]. This splint was formed of 2 vinyl sheets, an internal
sheet with a thickness of 1 mm to which 6 discs were attached, and
an external sheet with a thickness of 0.5 mm that was fenestrated
(patent number ES2380252B2; Figure 1).
The splint with the glass disks was worn by the volunteer for
48 hours to favour growth of the PL-biofilm, withdrawing it from
the oral cavity only during meals (it was stored in a physiological
sterile saline solution) and to perform oral hygiene using only the
mechanical removal of bacterial plaque with water without the use
of toothpaste or mouthrinse.
Application of the Chlorhexidine protocol on PL-biofilm
(Application 1)
After 48 hours, the glass disks were withdrawn one on one from
the splint from each volunteer (from right to left; in a distal-mesial
direction) at baseline, 30 seconds, 1, 3, 5 and 7 hours after
performing the following mouthrinses under supervision:
-A single, 30-second mouthrinse with 10 mL of sterile water
(negative control) (M-water).
OR
-A single, 30-second mouthrinse with 10 mL of 0.2% CHX
(Oraldine PerioH, Johnson and Johnson, Madrid, Spain) (M-
0.2% CHX).
On the day of the experiment, the volunteers were not allowed
to eat or drink during the course of the tests.
Collection of the different PL-biofilm samples started at 11:50
AM (baseline sample) and finished at 7 PM (final sample obtained
7 hours after performing the mouthrinse).
Using a balanced randomisation system, all volunteers per-
formed the 2 mouthrinses, with a washout period of 2 weeks
between each test.
Application of the Chlorhexidine protocol on salivary
flora (Application 2)
Applying a washout period (2 weeks) from application of the
CHX protocol on PL-biofilm, unstimulated saliva samples (1 ml)
were collected from each volunteer (in absence of the disk-holding
splint) at 30 seconds and 1, 3, 5 and 7 hours after performing the
following mouthrinses under supervision:
-A single, 30-second mouthrinse with 10 mL of sterile water
(negative control) (M-water).
OR
Figure 1. Individualized splint of the lower arch. A) Parts of the
individualized splint: 1. internal vinyl sheet; 2. polished glass discs; 3.
fenestrated external vinyl sheet. B) Clinical view of the individualized
splint with the glass discs inserted (arrows).
doi:10.1371/journal.pone.0083522.g001
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-A single, 30-second mouthrinse with 10 mL of 0.2% CHX
(Oraldine PerioH, Johnson and Johnson, Madrid, Spain) (M-
0.2% CHX).
On the day of the experiment, the volunteers were not allowed
to eat or drink during the course of the tests.
Collection of the different PL-biofilm samples started at 11:50
AM (baseline sample) and finished at 7 PM (final sample obtained
7 hours after performing the mouthrinse).
Using a balanced randomisation system, all volunteers per-
formed 2 mouthrinses, with a washout period of 2 weeks between
each test. The unstimulated saliva samples were collected using a
previously described method (the spitting method) [31].
Processing of the samples of PL-biofilm
The characteristics of the LIVE/DEADH BacLightTM fluores-
cence solution (Molecular Probes, Leiden, The Netherlands), as
well as its preparation, have been described by authors in a
previous study [11].
The glass disks were withdrawn from the splint and were
immediately submerged in 100 ml of fluorescence solution and
were kept in darkness at room temperature for 15 minutes.
Microscope observation was performed by a single investigator
who was unaware of the study design, using a Leica TCS SP2 laser
scanning spectral confocal microscope (Leica Microsystems
Heidelberg GmbH, Mannheim, Germany) with an HCX APOL
636/0.9 water-immersion lens.
Four randomly selected fields or XYZ series in the central part
of each disk were evaluated. These fields were considered as
representative of the whole after general examination. Fluores-
cence emission was determined in a series of XY images in which
each image corresponded with each one of the Z positions
(depth). The optical sections were scanned in one micron sections
from the surface of the biofilm to its base, measuring the
maximum thickness of the field and subsequently the mean
thickness of the biofilm of the corresponding sample. In
accordance with other authors [32], the maximum thickness of
biofilm field was defined as the distance between the substrate
and the peaks of the highest cell clusters. The biofilm maximum
thickness of each field was divided into 3 zones or equivalent
layers: outer layer (layer 1), middle layer (layer 2) and inner layer
(layer 3).
The capture of the data was done with the same settings in all
cases. The spatial scan mode (xyz) and the 102461024 pixels scan
format resolution were used. The Argon-ion and DPSS laser were
used at a 13% and 78% of maximum intensity, respectively. The
values for the pinhole, zoom and scan speed were 121.58 microns,
1 and 400 Hz, respectively. The only values that were different
depending on the sample were the offset (range between 21% to
1%) and PMT gain which was different for channel red and green
Figure 2. Mean percentages of bacterial viability in saliva and de novo PL-biofilm under basal conditions and at different times after
a single mouthrinse of sterile water and 0.2% Chlorhexidine. A) Intra-mouthrinse differences; B) Inter-mouthrinse differences; C) Inter-
ecosystem differences.
doi:10.1371/journal.pone.0083522.g002
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been higher for red in basal samples and higher for green in
30 seconds and the following in time samples. These values were
always adjusted to get a good quality capture without background
noise, avoiding excessive saturation of the brightest pixels of the
image. As the technician was blind to the experiment, they were
advised to make the adjustments always consistent with what was
seeing by the objective of the microscope, obtaining an image
which was the closest as possible to reality.
Quantification of bacterial viability in the series of XY images
was determined using cytofluorographic analysis (Leica Confocal
Software). In this analysis, the images of each fluorochrome were
defined as ‘‘channels’’ (SYTO 9 occupies the green channel and
PI the red channel). Square capture masks were used to measure
the area occupied (mm2) by the pixels in each channel,
determining the total area occupied by the biofilm and the
corresponding percentage of viability. The intensity ranges that
were considered as positive signal were between 100 and 255.
Determination of the mean percentage of bacterial viability in
each field required sections with a minimum area of biofilm of
250 mm2, and the mean percentage of bacterial viability of the
biofilm was calculated for the corresponding sample and for each
biofilm layer.
Processing of the saliva samples
The characteristics of the LIVE/DEADH BacLightTM fluores-
cence solution (Molecular Probes, Leiden, The Netherlands), as
well as its preparation, have been described by authors in a
previous study [11].
Processing of the saliva samples, as well as counting of viable
and non-viable bacteria have been described by authors in
previous studies [11,33,34]. The observations were performed by 2
researchers who were not aware of the study design, using an
Olympus BX51 microscope (Olympus, Tokyo, Japan) fitted with a
filter set for fluorescein and Texas Red. The excitation/emission
maxima are about 480/500 nm for SYTO 9 stain and 490/
635 nm for propidium iodide. In relation to objective lens
properties, Mag 1006 and NA 1.25.
Table 1. Mean percentages of bacterial viability in PL-biofilm, as well as intra-mouthrinse and inter-mouthrinse comparisons.
Mean ± Standard Deviation (%)
BASAL 30 SEC 1 H 3 H 5 H 7 H
M-water
Layer 1 85.3666.55 85.27613.10 88.3069.62 90.8268.91 88.9868.51 90.9365.94
Layer 2 79.8167.28 73.08615.13 78.44616.56 84.44610.32 81.34612.81 85.2067.06
Layer 3 66.83627.28 45.80633.35 49.39629.78 56.73631.46 55.43624.91 61.96624.00
M-0.2% CHX
Layer 1 79.9466.21 5.2066.19 15.13615.43 35.42615.53 21.70619.74 27.04622.64
Layer 2 82.2167.83 5.0566.43 16.54615.61 36.70616.42 24.83620.62 28.65620.76
Layer 3 71.80617.43 4.9765.04 15.16610.21 35.16614.83 27.44613.45 40.04620.37
INTRA-MOUTHRINSE ANALYSIS
BASAL 30 SEC 1 H 3 H 5 H 7 H
M-water
Layer 1 vs. Layer 2 p,0.05 p#0.001 p#0.001 p#0.001 p#0.001 p#0.001
Layer 1 vs. Layer 3 – p#0.001 p#0.001 p#0.001 p#0.001 p#0.001
Layer 2 vs. Layer 3 – p#0.001 p#0.001 p#0.001 p#0.001 p#0.001
M-0.2% CHX
Layer 1 vs. Layer 2 – – – – – –
Layer 1 vs. Layer 3 – – – – – p,0.05
Layer 2 vs. Layer 3 p,0.05 – – – – p,0.05
INTER-MOUTHRINSE ANALYSIS
BASAL 30 SEC 1 H 3 H 5 H 7 H
M-water vs. M-0.2% CHX
Layer 1 vs. Layer 1 p,0.05 p#0.001 p#0.001 p#0.001 p#0.001 p#0.001
Layer 2 vs. Layer 2 – p#0.001 p#0.001 p#0.001 p#0.001 p#0.001
Layer 3 vs. Layer 3 – p#0.001 p#0.001 p,0.05 p,0.05 p,0.05
Mean percentages of bacterial viability in PL-biofilm under basal conditions and in the samples collected at 30 seconds and 1, 3, 5, and 7 hours after a single mouthrinse
of sterile water and 0.2% Chlorhexidine differentiating between the 3 biofilm layers, as well as intra-mouthrinse and inter-mouthrinse comparisons.
– Not a statistically significant difference; M-water = a single, 30-second mouthrinse with 10 mL of sterile water; M-0.2% CHX = A single, 30-second mouthrinse with
10 mL of 0.2% Chlorhexidine; BASAL = Biofilm sample collected under basal conditions; 30 SEC = Biofilm sample collected at 30 seconds after the application of the
different mouthrinses; 1 H = Biofilm sample collected 1 hour after the application of the different mouthrinses; 3 H = Biofilm sample collected 3 hours after the
application of the different mouthrinses; 5 H = Biofilm sample collected 5 hours after the application of the different mouthrinses; 7 H = Biofilm sample collected
7 hours after the application of the different mouthrinses; the biofilm maximum thickness of each field was divided into 3 zones or equivalent layers: outer layer (layer
1), middle layer (layer 2) and inner layer (layer 3).
doi:10.1371/journal.pone.0083522.t001
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The count of viable and non-viable bacteria was performed at
high magnification (6100) on 20 fields (10 fields per slide) that
presented a minimum of 100 bacteria (bacterial aggregates were
excluded). The mean percentage of viable bacteria was calculated
for each saliva sample.
Statistical analysis
The results were analysed using the PASWH Statistics Base 18
package for Windows (IBM, Madrid, Spain). The intraclass
correlation coefficient (ICC, 2-factor model, random effects) and
the degree of homogeneity of the elements from the ‘‘absolute
agreement’’ perspective were calculated for the intra-observer and
inter-observer analysis of the epifluorescence microscopy tech-
nique. The data on thickness and bacterial viability in PL-biofilms,
as well as bacterial viability in saliva were expressed as mean and
standard deviation of the mean. All of the variables analysed
presented a normal distribution, which was determined using the
Kolmogorov-Smirnov test. One-way ANOVA with repeated
measures was used for intra-mouthrinse comparisons using all of
the PL-biofilm samples. Two-way ANOVA with repeated
measures was used for intra-mouthrinse (differentiating between
the 3 biofilm layers), inter-mouthrinse and inter-ecosystem
comparisons using all PL-biofilm and saliva samples. Three-way
ANOVA with repeated measures was used for inter-mouthrinse
(differentiating between the 3 biofilm layers) comparisons using all
of the PL-biofilm samples. Pairwise comparisons (with Bonferroni
adjustment) were used for the analysis of intra- and inter-
mouthrinse (including differentiating between the 3 biofilm layers),
as well as inter-ecosystem comparisons between 2 biofilm and
saliva samples. Statistical significance was taken as a P value less
than 0.05.
Results
In the intra-observer analysis of the epifluorescence microscopy
technique, the ICC mean value was 0.92 (P,0.001) and in the
inter-observer analysis, the ICC mean value was 0.87 (P,0.001).
Thickness, bacterial viability and structural characteristics
of PL-biofilm
The mean values of PL-biofilm thickness under basal conditions
were 18.1561.17 mm in the M-water and 22.5467.64 mm in the
M-0.2% CHX (ranged from 11.75 mm to 33.00 mm). The mean
values of PL-biofilm viability under basal conditions were
77.33610.59% in the M-water and 77.8969.10% in the M-
0.2% CHX (ranged from 62.04% to 94.71%).
In relation to the biofilm structural characteristics, an open and
heterogeneous architecture model was observed in the biofilm
samples, with the presence of fluid-filled channels and bubble-like
structures.
0.2% CHX: substantivity and influence on PL-biofilm
thickness
Figure 2 shows the mean percentages of bacterial viability in
PL-biofilm and saliva under basal conditions and at 30 seconds
and 1, 3, 5, and 7 hours after the M-water and M-0.2% CHX,
including the intra-mouthrinse and inter-mouthrinse comparisons.
In comparison with the baseline, the amount of viable bacteria
was similar in all of the PL-biofilm samples taken after the M-
water. In comparison with the baseline, the percentage of viable
bacteria decreased significantly at 30 seconds after the M-0.2%
CHX (77.9069.10% vs 5.0865.82%; p,0.001), detecting a
significant antibacterial effect up to 7 hours after the mouthrinse
(77.9069.10% vs 31.92620.17% p,0.001). In comparison with
Table 2. Mean values of thickness (mm) in PL-biofilm, as well as the intra-treatment and inter-treatment comparisons.
Mean ± Standard Deviation (mm)
BASAL 30 SEC 1 H 3 H 5 H 7 H
M-water 19.3265.41 18.0062.66 22.2565.38 20.9865.12 23.8764.76 23.9063.92
M-0.2% CHX 23.4367.64 15.7661.87 13.4662.54 15.3562.92 17.5163.88 15.5562.31
INTRA-MOUTHRINSE ANALYSIS
BASAL vs. 30 SEC BASAL vs. 1H BASAL vs. 3 H BASAL vs. 5H BASAL vs. 7H
30 SEC vs. 1H 30 SEC vs. 3H 30 SEC vs. 5H 30 SEC vs. 7H
M-water – – – – –
p,0.05 – p,0.05 p,0.05
M-0.2% CHX – p,0.05 p,0.05 – p,0.05
– – – –
INTER-MOUTHRINSE ANALYSIS
BASAL 30 SEC 1 H 3 H 5 H 7 H
M-water vs.
M-0.2% CHX
– p,0.05 p#0.001 p#0.001 p,0.05 p#0.001
Mean values of thickness (mm) in PL-biofilm under basal conditions and at 30 seconds and 1, 3, 5, and 7 hours after a single mouthrinse of sterile water and 0.2%
Chlorhexidine, as well as the intra-treatment and inter-treatment comparisons.
– Not a statistically significant difference; M-water = a single, 30-second mouthrinse with 10 mL of sterile water; M-0.2% CHX = A single, 30-second mouthrinse with
10 mL of 0.2% Chlorhexidine; BASAL = Biofilm sample collected under basal conditions; 30 SEC = Biofilm sample collected at 30 seconds after the application of the
different mouthrinses; 1 H = Biofilm sample collected 1 hour after the application of the different mouthrinses; 3 H = Biofilm sample collected 3 hours after the
application of the different mouthrinses; 5 H = Biofilm sample collected 5 hours after the application of the different mouthrinses; 7 H = Biofilm sample collected
7 hours after the application of the different mouthrinses.
doi:10.1371/journal.pone.0083522.t002
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the values obtained 30 seconds after the M-0.2% CHX, a
significant recovery of the bacterial population was observed in
the later saliva samples (after 3 hours) taken after the mouthrinse.
In comparison with M-water, the amount of viable bacteria was
significantly lower at 30 seconds after the M-0.2% CHX
(68.05618.99% vs 5.0865.82%, p,0.001), detecting a significant
antibacterial effect up to 7 hours after the mouthrinse
(79.14612.42% vs 31.92620.17%; p,0.001).
Table 1 shows the mean percentages of viable bacteria in PL-
biofilm under basal conditions and in the samples collected at
30 seconds and 1, 3, 5, and 7 hours after the M-water and M-
0.2% CHX, differentiating between the 3 biofilm layers, as well
as intra-mouthrinse and inter-mouthrinse comparisons. Differen-
tiating between the 3 biofilm layers, in M-water and M-0.2%
CHX, the amount of viable bacteria under basal conditions was
significantly higher in the outermost layers with respect to deeper
layers. In comparison with M-water, the amount of viable
bacteria was significantly lower in the 3 biofilm layers in all of
the biofilm samples taken after the M-0.2% CHX (p,0.001 in
all comparisons).
Table 2 shows the mean values of thickness (mm) in PL-biofilm
under basal conditions and at 30 seconds and 1, 3, 5, and 7 hours
after the M-water and M-0.2% CHX, as well as the intra-
treatment and inter-treatment comparisons. In comparison with
the baseline values, M-0.2% CHX provoked a significant
reduction effect on biofilm thickness at 1 hour, 3 hours and
7 hours after mouthrinse (p,0.05 in all comparisons). In
comparison with M-water, the biofilm thickness was significantly
lower in all of the biofilm samples taken after the M-0.2% CHX.
0.2% CHX substantivity: PL-biofilm vs. saliva
Figure 2 shows the mean percentages of bacterial viability in
PL-biofilm and saliva under basal conditions and at 30 seconds
and 1, 3, 5, and 7 hours after the M-water and M-0.2% CHX,
including the inter-ecosystem comparisons.
The mean bacterial viability in saliva under basal conditions
was significantly higher than that detected in PL-biofilm
(92.8661.80% in the M-water and 92.2664.11% in the M-
0.2% CHX vs 77.4467.48% in the M-water and 77.8969.10% in
the M-0.2% CHX; p,0.001). At 30 seconds after M-0.2% CHX,
the levels of viable bacteria detected in saliva were significantly
lower than those observed in PL-biofilm (0.8061.20% vs
5.0865.82%; p,0.05). At 1 and 3 hours after M-0.2% CHX,
the levels of viable bacteria detected in saliva and PL-biofilm were
similar. The difference in the percentage of viable bacteria
detected in saliva was significantly higher than that observed in
PL-biofilm at 5 hours (55.13619.96% vs 24.66616.66%; p,0.05)
and at 7 hours after M-0.2% CHX (76.86612.00% vs
31.91620.17%; p,0.001) (Figures 3 and 4).
Discussion
Methodological approach
In the majority of published series, measurement of CHX
antimicrobial activity in saliva has been performed using plate
culture microbiological techniques [35–37]. However, in a recent
study, we have demonstrated that epifluorescence microscopy
using the SYTO 9/propidium iodide dual stain (LIVE/DEADH
BacLightTM) was an effective method for quantifying the
antibacterial activity of CHX on salivary flora in real-time [11].
In the majority of studies, the number of volunteers who wore
the removable appliances ranged from 3 to 10 [18,20,26,38–40].
Due to the marked inter-individual variability detected on the
characteristics of PL-biofilm [2,17,20,27,39], a group of 15
individuals was selected in the present series. With regard to the
type of removable appliance used to collect the supragingival
dental plaque, Wood et al. [17,41], Watson et al. [4], and
Robinson et al. [42] used the ‘‘Leeds in situ device’’, composed
Figure 3. Images representing the changes in bacterial viability in the saliva. A) Sample collected under basal conditions; B), C), D) Sample
collected at 30 seconds, 5 and 7 hours respectively after a single mouthrinse of 0.2% Chlorhexidine.
doi:10.1371/journal.pone.0083522.g003
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of a nylon ring holding an enamel substrate, as it has been
previously described [43], on which the PL-biofilm grew. Some
authors [24,39,44,45] designed 2 bilateral mandibular stents
(spanning the posterior buccal surfaces from the first premolar to
first molar), each of which contained several disks, but other
different types of individualised acrylic splints for growing PL-
biofilm have also been used [2,3,5,20,22,25]. In the present series,
we designed individualised splints for each volunteer formed of 2
vinyl sheets, an internal sheet to which 6 discs were attached, and
an external sheet that was fenestrated to permit contact of the
vestibular surface of the discs with the saliva whilst protecting them
from the action of the cheeks and tongue. Several discs were
positioned on each hemi-arch and inserted towards the interdental
area between 2 adjacent teeth in order to imitate an approximal
PL-biofilm which is only minimally influenced by the shear forces
of the oral soft tissues. This particular design ensured that the
biofilm was not touched or disturbed during removal or
repositioning of the appliance [34].
A number of solid substrates of different characteristics have
been used in the published studies on PL-biofilm, including human
enamel [17,21,22,24,45], bovine enamel [5,25,40], bovine dentine
[27,40], hydroxyapatite [23], and polished glass [2,3,20,21].
Although the roughness of the surface of the substrate and its
free energy are considered to be important factors for the in vivo
growth of PL-biofilm [2], Netuschil et al. [21] found no major
differences in the thickness of 2-day PL-biofilm on using enamel or
glass disks; some authors recommend using glass to avoid any
optical disturbance due to the known autofluorescence of enamel
[21,26]. On the basis of these findings, in the present series, glass
disks were used for in vivo growth of the 2-day PL-biofilm.
In the majority of papers on PL-biofilm, the time for which the
appliance remained in the oral cavity varied between 4 hours
[24,39,44] and 7 days [4,5,42], depending on the type of PL-
biofilm to be analysed. Specifically, Auschill et al. [2] demonstrat-
ed that the mean thickness of 48-hour PL-biofilm -with a range
from 14 to 150 mm- was not affected by the position of the
removable device within the oral cavity (maxillary buccal region vs.
mandibular buccal region) or by the position of the disk (distal vs.
mesial; right vs. left). In addition, Arweiler et al. [20] observed that
the disk location in the oral cavity affected neither the mean
viability values -with a range from 64% to 77%- nor the bacterial
viability pattern in the 48-hour PL-biofilm. On the basis of these
results, we designed individualised splints of the lower arch
containing several disks, which were analysed from right to left; in
a distal-mesial direction.
Thickness, bacterial viability and structural characteristics
of PL-biofilm
In accordance with a high number of authors [2,17,20,22,27],
in the present study, 2-day PL-biofilms analysed by CLSM showed
an open complex, and heterogeneous architecture model with the
presence of channels and voids and ‘‘bubble-like structures’’
(Figure 5).
The majority of authors who analysed the in situ PL-biofilm
emphasised the great variation detected in PL-biofilm thickness
between different individuals [2,18,22]; this condition was also
observed in the present study (mean values of PL-biofilm thickness
was 20 mm ranging from 11.75 mm to 33.00 mm), indicating that
Figure 4. Images representing the changes in bacterial viability in de novo PL-biofilm. A) Sample collected under basal conditions; B), C),
D) Sample collected at 30 seconds, 3 and 7 hours respectively after a single mouthrinse of 0.2% Chlorhexidine.
doi:10.1371/journal.pone.0083522.g004
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‘‘the height of the oral biofilms formed depended on the plaque-forming rate of
the individual donors’’ [22].
The in situ studies published on PL-biofilm viability over 2 and
3 day periods were relatively consistent, with authors reporting
mean bacterial viability values between 60% and 77% [3,20,28];
accordingly, in the present series, the PL-biofilm viability was
approximately 80%. Consequently, vital micro-organisms are
located on and embedded in dead layers, which may be
responsible for further plaque growth [21]. Dead bacteria may
supplement living flora with all of the materials needed for rapid
growth [21] and protect them against antibacterial influences in
the oral environment [22]. For this reason, it has been stated that
dead cellular material is a major component of the biomass
during the initial stages of PL-biofilm accumulation and
development [21,22].
In some series, large inter-individual differences were found
among the subjects with regard to their PL-biofilm viability
distribution [27], so no general pattern for bacterial viability
distribution could be described [27,28]; accordingly, in the present
study, the PL-biofilm viability ranged from 62% to 95%.
However, it has been suggested that a relatively constant
ecological environment exists in each volunteer, which obviously
leads to a microbial identity pattern [20]. In this sense, Arweiler
et al. [20] detected a great variation in the bacterial viability values
in the 2-day PL-biofilms for the different biofilm layers, identifying
3 viability patterns: the first pattern was when a high number of
dead bacteria were found in layers nearest the substrate, increasing
in higher layers and then ending with low values at the outmost
surface of the PL-biofilm; the second pattern was when these
bacteria were superponed by new, vital bacteria, or some still vital
or cultivable bacteria proliferated, forming a new layer of vital PL-
biofilm; and the third pattern was when PL-biofilms started with
high viability values adjacent to the substrate surface, and then
decreased at their external aspect. In our study, despite the high
variability detected in bacterial viability distribution, a viability
pattern could be identified, which was based on a low viability
percentage observed in layers nearest the substrate, increasing in
higher layers.
In accordance with a large number of authors, 2-day PL-biofilm
analysed in situ by CLSM showed an open complex, and
heterogeneous architecture model and is characterised by the
presence of a complex system of channels and voids described as
an integral part of biofilm structure [2,17,20,22,27].
0.2% CHX: substantivity and influence on PL-biofilm
thickness
To the best of the author’s knowledge, there are few papers in
which the CHX antimicrobial effect on PL-biofilm derived from a
single application has been studied in situ, and the treatment was
practiced ex vivo in both [27,28]. In 2001, Zaura-Arite et al. [27]
concluded that only minor and superficial bactericidal effects of
0.2% CHX were obtained on PL-biofilm, with a thickness less
than 65 mm. On the other hand, it’s very interesting to note that
the subjects brushed their teeth twice a day (without the presence
of intraoral appliances) with a NaF toothpaste [27], which could
have conditioned the results obtained by these authors. On the
contrary, von Ohle et al [28] demonstrated that CHX treatment
significantly reduced the bacterial viability in the 3-day PL-
biofilms during exposure to sucrose (67% in control biofilm
compared to 2% and 0.7% in CHX-treated biofilms at 1 and
10 minutes, respectively). In accordance with these authors (28), in
our study, the 0.2% CHX mouthrinse for 30 seconds significantly
reduced the PL-biofilm viability (78% in basal conditions vs 5% at
30 seconds after the CHX application).
It has been stated that the concept ‘‘penetration’’ plays a more
important role in in situ PL-biofilms, where a single application of
an antimicrobial agent is tested [25]. In the present series, 0.2%
CHX inactivated bacteria from the top down and layer by layer of
PL-biofilm was killed with a similar efficacy in all regions. The rate
and extent of antimicrobial agent penetration depend on factors
including the biofilm structure and composition [4,17], and
perhaps, most importantly, biofilm thickness [46] as well as the
physicochemical properties of the solute [4,17]. On the other
hand, although other very interesting aspects are based on solute
penetration during brief exposure periods (,2 minutes), it is
relatively unexplored [4]. In this sense, von Ohle et al. [28] used a
simple diffusion model to calculate CHX concentration as a
function of depth and time of application on a 3-day in situ PL-
biofilm, assuming that a concentration of 0.1% CHX would be a
clinically relevant concentration. The model predicts that if the
thickness of the biofilm was reduced to 100 mm, the exposure time
would be reduced to ,2 minutes to achieve 0.1% CHX at the
base of biofilm; if it was reduced to 30 mm, then it would only take
12 seconds. These observations could justify the results of 0.2%
CHX antimicrobial activity on 2-day PL-biofilm obtained in the
present study.
Figure 5. Visualization of channels (A, yellow star) and voids (B, white star) in a single cross sectional plane from X, Y and Z axis
images obtained by the CLSM from a baseline sample. The presence of both channels and voids shows a heterogeneous architecture model.
doi:10.1371/journal.pone.0083522.g005
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None of the previously described studies on CHX antimicrobial
effect on PL-biofilm derived from a single application evaluated
the CHX substantivity on PL-biofilm and the influence on its
thickness [27,28]. In the present series, the antimicrobial activity of
0.2% CHX was still detectable 7 hours after the mouthrinse, at
which point the reduction in viability was 46%. A significant
recovery in bacterial viability was detected in the post-mouthrinse
biofilm samples collected after 3, 5 and 7 hours in comparison
with the viability at 30 seconds after the CHX mouthrinse
(especially in the biofilm layer 3 at 7 hours). With regard to the
influence of 0.2% CHX mouthrinse on the PL-biofilm thickness,
significant reductions in relation to baseline were detected at 1, 5
and 7 hours after application of antiseptic. In comparison to M-
water, mean values of PL-biofilm thickness detected were
significantly lower at 5 and 7 hours after M-0.2% CHX, which
might suggest a possible anti-plaque effect derived from the single
application of antiseptic.
Substantivity of 0.2% CHX on saliva vs. PL-biofilm
Tomás et al. [11] stated that fluorescence assays could be
particularly useful to simultaneously analyse the effect of
antimicrobials that alter the cytoplasmic membrane integrity on
different oral ecosystems. However, there are no studies published
in the literature in which CHX substantivity on saliva and PL-
biofilm was compared. Under basal conditions, PL-biofilm showed
a significantly lower viability than that detected in salivary flora (a
difference in the percentage of viable bacteria of 15%). The
bacterial viability obtained in salivary flora agrees with previous
results published by our research group [11,33].
Numerous authors have demonstrated that bacteria growing in
in vitro structured communities can be 10–1,000 times more
resistant to antimicrobial treatment than those grown in
planktonic phase [1,47]. In the present series, bacteria growing
in in situ 2-day PL-biofilm were 5 times more resistant (at
30 seconds) to 0.2% CHX mouthrinse than those present in
salivary flora (viability percentages of 5% and 1%, respectively).
However, 0.2% CHX mouthrinse showed higher substantivity
(sustained antibacterial activity) on de novo PL-biofilm than on
salivary flora at 5 and 7 hours after CHX application (viability
percentage of 25% and 32% vs. 55% and 77%, respectively).
This condition might be related to the slower growth rate of PL-
biofilm [48,49] or the presence of an open architecture with
channels and voids, which would presumably provide direct
communication between the oral environment and the enamel
surface [17]. These ‘‘circulatory’’ channels and voids could have
important implications for the movement of tooth damaging
organic acids, bacterial toxins, and other antigens, as well as for
the delivery of antimicrobial agents to the desired targets within
the PL-biofilm [17]. In this sense, although it has been assumed
that dead bacteria and exopolymeric substances impede fast
penetration of the antimicrobials through the biofilm, on the
contrary, other authors stated that PL-biofilm may also
contribute to a reservoir function for antimicrobial agents [14].
A better understanding of the in situ antibacterial activity of
CHX on different oral ecosystems could contribute to increase the
clinical efficacy of CHX in the prevention and treatment of the
oral biofilm-associated diseases.
Conclusion
After a single mouthrinse of the 0.2% CHX formulation tested
in the present study, the 2-day PL-biofilm presented a significantly
higher resistance to this antiseptic in situ than that observed in
salivary flora. However, this 0.2% CHX formulation showed a
higher substantivity on PL-biofilm than on salivary flora at 5 and
7 hours after mouth-rinsing, which could be related to the slower
growth rate of PL-biofilm and the possible reservoir function for
antimicrobial agents associated with the undisturbed de novo PL-
biofilm.
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